NEW YORK, July 17, 2019 /PRNewswire/ -- Bernstein Liebhard
LLP, a nationally acclaimed investor rights law firm, is
investigating potential securities fraud claims on behalf of
shareholders of CareDx Inc. ("CareDx" or the "Company") (NASDAQ:
CDNA) resulting from allegations that CareDx and/or its executives
may have issued materially misleading information to the investing
public.
If you purchased CareDx securities, and/or would like to
discuss your legal rights and options please visit CareDx CDNA
Shareholder Investigation or contact Matthew E. Guarnero toll free at (877)
779-1414 or MGuarnero@bernlieb.com.
In 2017, CareDx launched its AlloSure product for kidney
transplant recipients. AlloSure is designed to check for
cell-free DNA associated with organ rejection, a serious problem
with kidney transplants. AlloSure is currently responsible for 83%
of CareDx's total revenue.
On July 16, 2019, a report from
Kerrisdale Capital Management noted that the AlloSure test
manufactured by CareDx isn't nearly as popular as it seems because
it misses around 40% of organ rejections compared to the current
standard of care.
On this news, shares of CareDx dropped $4.83, or nearly 13%.
If you purchased CDNA securities, and/or would like to
discuss your legal rights and options please visit
https://www.bernlieb.com/cases/caredxinc-cdna-shareholder-lawsuit-class-action-fraud-stock-153/
or contact Matthew E. Guarnero toll
free at (877) 779-1414 or MGuarnero@bernlieb.com.
Since 1993, Bernstein Liebhard LLP has recovered over
$3.5 billion for its clients. In
addition to representing individual investors, the Firm has been
retained by some of the largest public and private pension funds in
the country to monitor their assets and pursue litigation on their
behalf. As a result of its success litigating hundreds of lawsuits
and class actions, the Firm has been named to The National
Law Journal's "Plaintiffs' Hot List" thirteen times and
listed in The Legal 500 for ten consecutive
years.
ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cdna-investigation-alert-bernstein-liebhard-llp-announces-investigation-of-caredx-inc-cdna-300886814.html
SOURCE Bernstein Liebhard LLP